Research

NICE guidance offers new NHS treatment for high cholesterol

Thousands of people with high cholesterol will soon have access to a new treatment option on the NHS, according to final NICE guidance published today.

Around 70,000 adults in England with primary hypercholesterolaemia or mixed dyslipidaemia, also known as high cholesterol, will now be eligible for treatment with bempedoic acid with ezetimibe, if statins cannot be taken, or have not worked for them.

Current standard treatment for high cholesterol includes dietary changes and statins for lowering low‑density lipoprotein cholesterol (LDL-C) levels. People may also be treated with ezetimibe and either alirocumab or evolocumab when their cholesterol levels are not lowered enough with the maximally tolerated dose of statins.

The new NICE guidance means bempedoic acid with ezetimibe will be offered as an option for people who are unable to use statins and whose high cholesterol is not well-controlled with ezetimibe alone.

Deputy Chief Executive and Director of the Centre for Health Technology Evaluation at NICE, Meindert Boysen, said: “High cholesterol, if left untreated, can lead to a range of serious health conditions. Although statins and other treatments are used successfully by a large portion of the population, some people may require other options to control their cholesterol.

“We are pleased to be able to recommend bempedoic acid with ezetimibe as a new treatment option for these individuals.”

Bempedoic acid with ezetimibe are both taken once daily in tablet form. They can be used as separate tablets (Nilemdo by Daiichi Sankyo, plus ezetimibe) or in a fixed-dose combination (Nustendi by Daiichi Sankyo).

The full guidance can be accessed here.

NHE Jan.Feb 21

NHE Jan/Feb 21

Creating a net zero NHS

NHE’s Jan/Feb 2021 edition focuses on the role of pharma working alongside the NHS, how we are working to digitise the health service and the ways in which the NHS can be involved in addressing the climate emergency.

Videos...

View all videos
BMC Whitepaper

Survey

How well do the NHS understand digital potential?

Recently we have been gathering primary data direct from those within the NHS on modernising NHS technology and the challenges faced around resource, training and service management.

Download the full whitepaper and read the full findings in our exclusive report to learn more.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all